← Back to all trials
Not Yet Recruiting
NCT05721677
CLABSI Prevention With Tissue Adhesive
Conditions: Central-line Associated Blood Stream Infections (CLABSI)
Sex: All
Ages: 0 Days – 18 Years
Phase: NA
Enrollment: 600
Sponsor: Rabin Medical Center
Summary
Our aim is to test the effect of tissue adhesive application at the Central-line exit-site on CLABSI rates in high-risk pediatric congenital heart disease patients.
Eligibility Criteria
Inclusion Criteria:All patients admitted to pediatric cardiac ICU (PCICU) defined as high-risk for CLABSI (any of):young age<1yweight ≤5 kgRisk Adjustment for Congenital Heart Surgery (RACHS) category ≥3STS-EACTS Congenital Heart Surgery Mortality Category (STAT) score 3-5preoperative length-of-stay (LOS) >1 daypreoperative ventilator supportpresence of a genetic abnormalitypre-operative blood product exposureextracorporeal membrane oxygenation (ECMO) supportExclusion Criteria:Patients with on-going bacteremiapatients with pre-existing central-line or peripherally inserted central catheter (PICC)parental refusal to participate.
Source: ClinicalTrials.gov (NCT05721677). StuddyBuddy aggregates publicly available trial information.